Test strip for detecting CD2v and MGF360 mucous membrane antibodies of African swine fever viruses and application of test strip
A technology of African swine fever virus and African swine fever, which is applied to test strips for detecting African swine fever virus CD2v and MGF360 mucosal antibodies and its application field, which can solve the problem of difficult real-time detection, low sensitivity and high cost in grassroots farms and other problems, to achieve the effect of high uniformity, high sensitivity and good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0038] Example 1 Preparation of recombinant protein CD2v and recombinant protein MGF360
[0039] 1. Construction of recombinant bacteria for the preparation of recombinant protein CD2v
[0040] Referring to the complete gene sequence of the first African swine fever SY18 in my country (MH766894, EP402R, 73369-74451) published by the NCBI database, the gene of the recombinant protein CD2v was designed. The sequence is shown in SEQ ID NO: 1, and the amino acid sequence of the recombinant protein CD2v is shown in shown in SEQ ID NO:2. The gene of the recombinant protein CD2v was obtained by gene synthesis (by Nanjing GenScript Biotechnology Co., Ltd.), and the gene of the recombinant protein CD2v was inserted between the polyclonal restriction sites EcoRI and HindIII of the vector pET-32a(+). , the recombinant plasmid pET-32a-CD2v was obtained.
[0041] By the "heat shock" method, the recombinant plasmid pET-32a-CD2v was transformed into E. coli BL21(DE3) competent cells to obta...
Example Embodiment
[0049] Example 2 Preparation of the sample diluent of the present invention
[0050] The sample diluent of the present invention: contains African swine fever virus double protein-marker. The African swine fever virus double protein-label is a mixture of quantum dot microsphere-labeled recombinant protein CD2v and quantum dot microsphere-labeled recombinant protein MGF360.
[0051] The preparation method of the sample diluent of the present invention comprises the following steps:
[0052] (1) Preparation of recombinant protein CD2v labeled with quantum dot microspheres
[0053] The quantum dot microsphere suspension with a concentration of 1.2 μg / μL (purchased from Beijing Nano Crystal Biotechnology Co., Ltd., product number is FM610C, hydrated particle size is 120 nm) and a concentration of 0.02 M, pH 7.0 MES buffer by volume. Mix at a ratio of 1:1, then add EDC (1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride) and 10 mg / mL NHS (N -Hydroxysuccinimide), incubat...
Example Embodiment
[0060] The preparation of embodiment 3 test strips of the present invention
[0061] like Figure 3-5 , the test strips for detecting African swine fever virus CD2v and MGF360 mucosal antibodies include a bottom plate 2, and a sample pad 3, a nitrocellulose membrane 4 and a water absorption pad 7 are arranged on the bottom plate in sequence. The nitrocellulose membrane 4 is provided with a detection line 5 and a quality control line 6. The detection line 5 is set near the side of the sample pad, and the detection line is coated with mouse anti-pig SC protein monoclonal antibody; the quality control line 6 is close to the absorbent pad 7 Set on one side, the quality control line is coated with purified protein from African swine fever positive serum.
[0062] 1. Preparation of purified protein from African swine fever-positive serum
[0063] (1) Sample preparation
[0064]Using recombinant protein CD2v and recombinant protein MGF360 as immunogens, adult New Zealand white rab...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap